Evidence map›Paper›PMID 32451366›Full record

ArticleBMJ global health2020

The potential effects of widespread community transmission of SARS-CoV-2 infection in the World Health Organization African Region: a predictive model.

Joseph Waogodo Cabore, Humphrey Cyprian Karamagi, Hillary Kipruto, James Avoka Asamani, Benson Droti, Aminata Binetou Wahebine Seydi, Regina Titi-Ofei, Benido Impouma, Michel Yao, Zabulon Yoti and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 3 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 3 syntheses or guidelines pooled it, 152 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Design, Synthesis and Biological Exploration of NovelInternational journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Conflicting COVID-19 excess mortality estimates.Lancet (London, England) · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Joseph Waogodo CaboreDirector of Programme Management, World Health Organization Regional Office for Africa, Brazzaville, Congo.
Humphrey Cyprian KaramagiData Analytics and Knowledge Management, World Health Organization Regional Office for Africa, Brazzaville, Congo karamagih@gmail.com.ORCID http://orcid.org/0000-0002-6277-2095
Hillary KiprutoUniversal Health Coverage - Life Course, World Health Organization Regional Office for Africa, Harare, Zimbabwe.ORCID http://orcid.org/0000-0002-3879-1712
James Avoka AsamaniUniversal Health Coverage - Life Course, World Health Organization Regional Office for Africa, Harare, Zimbabwe.ORCID http://orcid.org/0000-0003-0620-6010
Benson DrotiUniversal Health Coverage - Life Course, World Health Organization Regional Office for Africa, Brazzaville, Congo.ORCID http://orcid.org/0000-0003-0581-1542
Aminata Binetou Wahebine SeydiData Analytics and Knowledge Management, World Health Organization Regional Office for Africa, Brazzaville, Congo.ORCID http://orcid.org/0000-0001-5582-2579
Regina Titi-OfeiData Analytics and Knowledge Management, World Health Organization Regional Office for Africa, Brazzaville, Congo.ORCID http://orcid.org/0000-0002-8753-6021
Benido ImpoumaHealth Emergencies Programme, World Health Organization Regional Office for Africa, Brazzaville, Congo.ORCID http://orcid.org/0000-0001-6363-7146
Michel YaoHealth Emergencies Programme, World Health Organization Regional Office for Africa, Brazzaville, Congo.
Zabulon YotiHealth Emergencies Programme, World Health Organization Regional Office for Africa, Brazzaville, Congo.ORCID http://orcid.org/0000-0001-7817-0382
Felicitas ZawairaAssistant Regional Director, World Health Organization Regional Office for Africa, Brazzaville, Congo.
Prosper TumusiimeUniversal Health Coverage - Life Course, World Health Organization Regional Office for Africa, Brazzaville, Congo.ORCID http://orcid.org/0000-0001-6899-824X
Ambrose TalisunaHealth Emergencies Programme, World Health Organization Regional Office for Africa, Brazzaville, Congo.ORCID http://orcid.org/0000-0001-6436-3415
Francis Chisaka KasoloCountry Support, World Health Organization Regional Office for Africa, Brazzaville, Congo.ORCID http://orcid.org/0000-0002-3725-2629
Matshidiso R MoetiRegional Director, World Health Organization Regional Office for Africa, Brazzaville, Congo.ORCID http://orcid.org/0000-0002-3692-2395
World Health Organization Regional Office for Africa · CGWorld Health Organization - Zimbabwe · ZW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been unprecedented in its speed and effects. Interruption of its transmission to prevent widespread community transmission is critical because its effects go beyond the number of COVID-19 cases and deaths and affect the health system capacity to provide other essential services. Highlighting the implications of such a situation, the predictions presented here are derived using a Markov chain model, with the transition states and country specific probabilities derived based on currently available knowledge. A risk of exposure, and vulnerability index are used to make the probabilities country specific. The results predict a high risk of exposure in states of small size, together with Algeria, South Africa and Cameroon. Nigeria will have the largest number of infections, followed by Algeria and South Africa. Mauritania would have the fewest cases, followed by Seychelles and Eritrea. Per capita, Mauritius, Seychelles and Equatorial Guinea would have the highest proportion of their population affected, while Niger, Mauritania and Chad would have the lowest. Of the World Health Organization's 1 billion population in Africa, 22% (16%-26%) will be infected in the first year, with 37 (29 - 44) million symptomatic cases and 150 078 (82 735-189 579) deaths. There will be an estimated 4.6 (3.6-5.5) million COVID-19 hospitalisations, of which 139 521 (81 876-167 044) would be severe cases requiring oxygen, and 89 043 (52 253-106 599) critical cases requiring breathing support. The needed mitigation measures would significantly strain health system capacities, particularly for secondary and tertiary services, while many cases may pass undetected in primary care facilities due to weak diagnostic capacity and non-specific symptoms. The effect of avoiding widespread and sustained community transmission of SARS-CoV-2 is significant, and most likely outweighs any costs of preventing such a scenario. Effective containment measures should be promoted in all countries to best manage the COVID-19 pandemic.

Indexed as

Public HealthWorld Health OrganizationAfricaAgedBetacoronavirusCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralProbabilitySARS-CoV-2epidemiologyhealth systemsmathematical modelling

Identifiers

PMID32451366
PMCPMC7252960
OpenAlexW3026699536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.